St Thomas’ Hospital accelerates Candida auris detection and isolation using Vivalytics PCR platform
6 Oct 2025
Désirée Prossomariti, Guy’s and St Thomas’ NHS Foundation Trust, details the transformative impact of switching from culture-based testing to PCR for managing patients with Candida auris – an emerging infectious disease caused by a fungal pathogen that poses significant risk in hospital settings. Learn about limitations of traditional detection methods, the outbreak at St Thomas’ Hospital that prompted change, and the successful implementation of Vivalytic automated, cartridge-based PCR assays from Randox, which drastically reduced turnaround times from over 90 hours to just 26. This shift enabled faster patient isolation, reduced strain on biomedical scientists, and improved overall outbreak control. Prossomariti also shares operational insights and encourages other hospitals to consider PCR adoption for better patient management. Craig Ryan, Molecular Product Manager at Randox Laboratories Ltd., details how other hospitals can gain support from the company to make the switch to PCR.
SelectScience interview filmed at the IBMS Congress 2025 in Birmingham, UK.
About the company
Randox Laboratories Ltd.
Randox Laboratories Ltd. is a privately owned diagnostic reagent and equipment manufacturer and the leading British manufacturer of clinical chemistry reagents. Randox has over 25 years’ experience in research, development, manufacture and marketing of high quality diagnostic reagents and equipment for laboratory medicine.
The Randox portfolio includes the revolutionary Biochip Array Technology for application in genomics and proteomics, clinical chemistry automation systems, external quality assurance schemes, internet driven QC systems, quality control materials, clinical reagents and environmental diagnostics. The life sciences department offers a range of polyclonal antibodies and recombinant proteins, and the customer service team offers an assay development service. Randox is a significant investor in the development of new healthcare technology solutions.
Randox employs over 700 people, including 200 research scientists. Randox's success has been built on our philosophy - "we exist and expand through our customers".
Randox has sales and distribution agreements in 130 countries and international offices worldwide.
